European Commission high-level conference: centralisation to cost industry
This article was originally published in RAJ Devices
Executive Summary
The debate over the future of the European medical technology regulatory system involves controversial and difficult questions. For example, how do you fund a structure that has been identified as necessary to improve regulatory implementation and oversight and how do you tighten regulations and increase confidence, but in a way that still fosters innovation?